Jingxu Venture Capital
Overview
Jingxu Venture Capital (also known as Prosperico Ventures) is a Shanghai-based venture capital firm that specializes in healthcare and high-tech industry investments, focusing on emerging companies and buyouts.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Singlera Genomics Inc. | Dec 2020 | Series B | Co-investor |
| Nanjing Forssmann Medical Technology Co., Ltd. | Oct 2018 | Angel | Co-investor |
| Xynomic Pharmaceuticals | Aug 2018 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Jingxu Venture Capital based?
Jingxu Venture Capital is headquartered in Shanghai, China.
When was Jingxu Venture Capital founded?
Jingxu Venture Capital was founded in 2015.
How many portfolio companies does Jingxu Venture Capital have?
Jingxu Venture Capital has 4 portfolio companies in Caplight's dataset.
What are some companies in Jingxu Venture Capital's portfolio?
Recent investments visible on Caplight include Singlera Genomics Inc., Nanjing Forssmann Medical Technology Co., Ltd., Xynomic Pharmaceuticals, Singlera Genomics Inc., Xynomic Pharmaceuticals.
What was Jingxu Venture Capital's most recent investment?
Jingxu Venture Capital's most recent investment on Caplight was in Singlera Genomics Inc. in 2020.
What sectors does Jingxu Venture Capital focus on?
Jingxu Venture Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Jingxu Venture Capital focus on?
Jingxu Venture Capital typically invests at the Early stage.
What is Jingxu Venture Capital's AUM?
Jingxu Venture Capital's assets under management are estimated between $69.0M and $138.0M.